Cargando…

Clinical microbiology procedures handbook /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Garcia, Lynne Shore, Isenberg, Henry D.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, DC : ASM Press, ©2010.
Edición:3rd ed and 2007 update.
Colección:Reference Manual, ASM Press.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Dedication
  • contents
  • editorial board
  • how to use this handbook
  • abbreviations
  • preface
  • acknowledgments
  • reader response form
  • disclaimer
  • Volume 1
  • Procedure coding, reimbursement, and billing compliance
  • Chapter 1.1 : introduction
  • Chapter 1.2 : procedure coding, reimbursement, and billing compliance
  • Specimen collection, transport, and acceptability
  • Chapter 2.1 : collection, transport, and manipulation of clinical specimens and initial laboratory concerns
  • Aerobic bacteriology
  • Chapter 3.1 : introduction to the section
  • Chapter 3.2 : staining procedures
  • Chapter 3.3 : processing, isolation, detection, and interpretation of aerobic bacteriology cultures
  • Chapter 3.4 : blood cultures
  • Chapter 3.5 : body fluid cultures (excluding blood, cerebrospinal fluid, and urine)
  • Chapter 3.6 : catheter tip cultures
  • Chapter 3.7 : cerebrospinal fluid cultures
  • Chapter 3.8 : fecal and other gastrointestinal cultures and toxin assays
  • Chapter 3.9 : genital cultures
  • Chapter 3.10 : ocular cultures
  • Chapter 3.11 : respiratory tract cultures
  • Chapter 3.12 : urine cultures
  • Chapter 3.13 : wound cultures
  • Chapter 3.14 : leptospira culture
  • Chapter 3.15 : mycoplasma pneumoniae, mycoplasma hominis, and ureaplasma cultures from clinical specimens
  • Chapter 3.16 : guidelines for biochemical identification of aerobic bacteria
  • Chapter 3.17 : biochemical tests for the identification of aerobic bacteria
  • Chapter 3.18 : schemes for identification of aerobic bacteria
  • Anaerobic bacteriology
  • Chapter 4.1 : introduction
  • Chapter 4.2 : collection and transport of clinical specimens for anaerobic culture
  • Chapter 4.3 : culture media for anaerobes
  • Chapter 4.4 : examination of primary culture plates for anaerobic bacteria
  • Chapter 4.5 : incubation techniques for anaerobic bacteriology specimens
  • Chapter 4.6 : rapid disk, spot tests, and other methods for the identification of anaerobes
  • Chapter 4.7 : commercial kit overnight biochemical systems for the identification of anaerobes
  • Chapter 4.8 : rapid enzymatic systems for the identification of anaerobes
  • Chapter 4.9 : rapid biochemical tests (4 hours or less) for the identification of anaerobes
  • Chapter 4.10 : anaerobic gram-negative bacilli
  • Chapter 4.11 : anaerobic gram-positive bacilli
  • Chapter 4.12 : anaerobic cocci
  • Chapter 4.13 : suggestions for a practical scheme for the workup of anaerobic cultures
  • Chapter 4.14 : clostridium difficile as a pathogen involved in antimicrobial agent-associated diarrhea, colitis, and pseudomembranous colitis.
  • Volume 3
  • Viruses and chlamydiae
  • Chapter 10.1 : laboratory diagnosis of viral infections: introduction
  • Chapter 10.2 : selection, maintenance, and observation of uninoculated monolayer cell cultures
  • Chapter 10.3 : cell culture techniques: serial propagation and maintenance of monolayer cell cultures
  • Chapter 10.4 : specimen collection and processing
  • Chapter 10.5 : viral culture: isolation of viruses in cell cultures
  • Chapter 10.6 : isolation of chlamydia spp. In cell culture
  • Chapter 10.7 : direct detection of viruses and chlamydia in clinical samples
  • Immunology
  • Chapter 11.1 : immunology introduction
  • Chapter 11.2 : serologic diagnosis of group a streptococcal infections
  • Chapter 11.3 : detection of legionella antigen by direct immunofluorescence
  • Chapter 11.4 : urinary antigen detection for legionella spp.
  • Chapter 11.5 : laboratory diagnosis of syphilis
  • Chapter 11.6 : detection of borrelia burgdorferi antibodies
  • Chapter 11.7 : serodiagnosis of rickettsial infections
  • Chapter 11.8 : immunoassay detection of shiga toxin-producing escherichia coli
  • Chapter 11.9 : serodiagnosis of helicobacter pylori
  • Chapter 11.10 : total viable cell counting procedure
  • Chapter 11.11 : peripheral blood mononuclear cell cryopreservation method
  • Chapter 11.12 : lymphocyte proliferation assay
  • Chapter 11.13 : natural killer cell assays
  • Chapter 11.14 : quantitation of human interleukin 4, interleukin 6, and gamma interferon
  • Chapter 11.15 : flow cytometry whole-blood intracellular-cytokine assay using phorbol myristate acetate, ionomycin, and brefeldin a
  • Chapter 11.16 : whole-blood lymphocyte immunophenotyping using cell surface markers by flow cytometry
  • Chapter 11.17 : neutrophil function whole-blood flow cytometric test for leukocyte adhesion deficiency
  • Chapter 11.18 : flow cytometric test for chronic granulomatous disease
  • Chapter 11.19 : gamma interferon enzyme-linked immunospot assay
  • Molecular diagnostics
  • Chapter 12.1 : introduction
  • Chapter 12.2 : molecular methods for direct detection of microorganisms in clinical specimens
  • Chapter 12.3 : molecular methods for identification of cultured microorganisms
  • Chapter 12.4 : molecular methods for epidemiologic typing of microorganisms
  • Chapter 12.5 : molecular methods for antimicrobial agent resistance determination
  • Chapter 12.6 : appendix 12.6-1
  • unidirectional work flow and minimization of contamination
  • Epidemiologic and infection control microbiology
  • Chapter 13.1 : introduction
  • Chapter 13.2 : laboratory support for infection control: optimization by policy and procedure
  • Chapter 13.3 : policies for environmental sampling and culturing for infection control
  • Chapter 13.4 : outbreak investigations: laboratory and epidemiologic concepts
  • Chapter 13.5 : epidemiologic strain typing
  • Chapter 13.6 : culture of hospital water for legionellaceae.
  • Chapter 13.7 : culture and endotoxin assay of hemodialysis fluids
  • Chapter 13.8 : culture of peritoneal dialysis fluid
  • Chapter 13.9 : air cultures for fungi
  • Chapter 13.10 : microbiological assay of environmental and medical-device surfaces
  • Chapter 13.11 : surveillance cultures from immunocompromised hosts
  • Chapter 13.12 : culture of intravascular devices
  • Chapter 13.13 : culture of blood bank products
  • Chapter 13.14 : microbiological assessment of orthopedic surgery sites
  • Chapter 13.15 : quantitative culture of small-bowel contents
  • Chapter 13.16 : phenotypic characterization of organisms for epidemiologic purposes
  • Chapter 13.17 : screening for methicillin-resistant staphylococcus aureus
  • Chapter 13.18 : screening for vancomycin-resistant enterococci
  • Quality assurance, quality control, laboratory records, and water quality
  • Chapter 14.1 : quality assessment and improvement (quality assurance)
  • Chapter 14.2 : quality control
  • Chapter 14.3 : laboratory records
  • Chapter 14.4 : preparation and quality control of laboratory water
  • Biohazards and safety
  • Chapter 15.1 : introduction
  • Chapter 15.2 : biological safety and biohazard prevention
  • Chapter 15.3 : biohazard containment
  • Chapter 15.4 : laboratory instrumentation and equipment
  • Chapter 15.5 : special pathogens and employee safety
  • Chapter 15.6 : packing and shipping infectious substances
  • Chapter 15.7 : management of laboratory accidents
  • Chapter 15.8 : management of infectious waste
  • Bioterrorism
  • Chapter 16.1 : general introduction to bioterrorism
  • Chapter 16.2 : levels of laboratory safety
  • Chapter 16.3 : packing and shipping select agents
  • Chapter 16.4 : anthrax
  • bacillus anthracis
  • Chapter 16.5 : botulinumtoxin
  • clostridium botulinum
  • Chapter 16.6 : brucellosis
  • brucella spp.
  • Chapter 16.7 : plague
  • yersinia pestis
  • Chapter 16.8 : tularemia
  • francisella tularensis
  • Chapter 16.9 : melioidosis (burkholderia pseudomallei) and glanders (burkholderia mallei)
  • Chapter 16.10 : smallpox
  • variola major
  • Chapter 16.11 : unknown virus
  • Chapter 16.12 : q fever
  • coxiella burnetii
  • Chapter 16.13 : clinical laboratory bioterrorism readiness plan
  • Chapter 16.14 : avian influenza
  • Index.